AzTrials
AzTrials

Total Knee ReplacementNCT06929871

Mako Cementless TKA vs Mako Cemented TKA

A study testing Mako cementless TKA and Mako cemented TKA in people with Total Knee Replacement and Total Knee Replacement Surgery, run by University College, London at 1 site in United Kingdom.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The overall aims of this prospective, randomised, single-blinded controlled trial are to compare functional, radiological and clinical outcomes in Mako robotic-arm assisted cementless Total Knee Arthroplasty (TKA) versus Mako robotic-arm assisted cemented TKA. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Mako cementless TKA and Mako cemented TKA
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteUnited Kingdom
Study dates
29 Sep 2025to 1 Aug 2031
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient has symptomatic knee osteoarthritis requiring primary TKA
  • Patient and surgeon are in agreement that TKA is the most appropriate treatment
  • Patient is fit for surgical intervention following review by surgeon and anaesthetist
  • Patient is over 18 years old at time of surgery
  • Gender: male and female
  • Patient must be capable of giving informed consent and agree to comply with the postoperative review program
  • Patient must have sufficient postoperative mobility to attend follow-up clinics and allow for radiographs to be taken

Who cannot join

  • Patient is not suitable for routine primary TKA e.g. patient has ligament deficiency that requires a constrained prosthesis
  • Patient has bone loss that requires augmentation
  • Patient is not medically fit for surgical intervention
  • Patient requires revision surgery following previously failed correctional osteotomy or ipsilateral TKA
  • Patient has a DEXA scan with T-score < -2.5 at any point
  • Patient is immobile or has another neurological condition affecting musculoskeletal function
Show all 10Show fewer
  • Patient is less than 18 years at time of surgery
  • Patient is unable or unwilling to sign the informed consent form specific to this study
  • Patient is unable to attend the follow-up programme
  • Previous pathological fracture

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Jenni Tahmassebi, BSc MSc contact

+442034479403

jenni.tahmassebi1@nhs.net

United Kingdom1 site, 1 recruiting
  • UCL Hospitals NHS Foundation Trust

    London, NW1 2PG

    Jenni Tahmassebi, MSc, 07976856091, jenni.tahmassebi1@nhs.net

    Moneet Gill, MBBS

    Recruiting

Other trials in United Kingdom

About this study

Official title: A Prospective Randomised Controlled Trial Comparing Cementless Mako Robotic-arm Assisted Total Knee Arthroplasty Versus Cemented Mako Robotic-arm Assisted Total Knee Arthroplasty.

The overall aims of this prospective, randomised, single-blinded controlled trial are to compare functional, radiological and clinical outcomes in Mako robotic-arm assisted cementless Total Knee Arthroplasty (TKA) versus Mako robotic-arm assisted cemented TKA.

Read the detailed description

Osteoarthritis of the knee accounts approximately for 85% of the disease burden across the globe10. Almost one in six people is affected by knee arthritis and according to the latest National Joint Registry (NJR) report; over the last three years in England and Wales more than 100,000 patients underwent total knee replacement each year.

Registry-based studies have shown good clinical outcomes and survivorship following TKA, however despite these results aseptic loosening and lysis remain the leading indications for revision. Furthermore, there is a higher incidence of patient dissatisfaction compared to total hip arthroplasty, with up to 20% of patients reporting dissatisfaction in an otherwise uncomplicated TKA. There has been an exponential rise in the number of TKAs performed in the UK and around the world, with a sharp increase in the percentage of younger patients undergoing TKA11. Notwithstanding, younger patients have consistently shown poorer outcomes following TKAs and younger age has been recognised as a risk factor of aseptic loosening; thus raising a concern given the demographic trend of younger patients seeking TKA.

The optimal component fixation mode has been contentious, and it is yet to be established whether one is superior to the other. Early reports of cementless TKAs had risen concerns in relation to suboptimal fixation and early failure. However, since then, there has been a dramatic improvement in the design and technique of cementless TKA, reflected on several studies reporting promising and favourable outcomes with cementless fixation; a recent systematic review and meta-analysis has shown a 96% - 100% survival at ten- to 15-years. Proponents of the technique highlight the potential of biologic fixation and better osseointegration, given highly porous surfaces on TKA designs prevent a mismatch in stiffness and approximate the pore size and elasticity of trabecular bone. Moreover, cementless implants do not produce cement debris, averting the risk of cement degradation leading to prosthesis loosening. Commonly, cementless prostheses are more expensive than cemented, however a recent study reported a lower overall cost associated with cementless TKA; showing that the additional cost could be offset when additional variables are taken into account such as operating time, implant, cement and cementing accessories.

The evolution of surgical technology has led to the development of robotic-arm assisted TKA, which uses three dimensional images of each patient's unique anatomy to guide bone resection, implant positioning, and optimise limb alignment. The robotic arm interactive orthopaedic (RIO) system (Mako surgical) uses preoperative computerised tomography scans to build a computer-aided design (CAD) model of the patient's knee joint. The Mako robotic software processes this information to calculate the volume of bone requiring resection and creates a three-dimensional haptic window for the robotic arm to resect. The robotic arm has tactile and audio feedback to resect bone to a high degree of accuracy and preserve as much bone stock as possible. The surgeon can then plan and execute optimal sizing and positioning of the prosthesis to achieve the required bone coverage, minimise bone resection, and obtain the desired limb alignment. The Mako software also creates a patient-specific computer aided design model using the preoperative CT scan, which means that only bone anatomy is segmented. The surgeon is able to compensate for wear when creating the surgical alignment plan and uses intraoperative bone registration to map the patient's anatomy.

There are very few randomised prospective studies exploring clinical and radiological outcomes in cemented versus uncemented TKA. Prospective studies comparing functional outcomes between the treatment groups have been performed but the main limitation of these studies has been the inability to achieve the implant position to a high degree of accuracy. Furthermore, there is a paucity of long-term studies and limited data correlating radiological outcomes to clinical findings.

Since its introduction in 1974, radiostereometric analysis (RSA) has been widely used in the assessment of implant stability and survivorship in joint arthroplasty. The model-based RSA technique involves the insertion of inert tantalum beads into the bone around the prosthesis. These bone markers act as fixed reference points from which the spatial resolution and rotation of the implants are calculated. Early implant migration as assessed by RSA has been shown to accurately reflect the risk of loosening.

The most recent data comes from Hasan et al that conducted a RCT comparing the cementless Tritanium 3D-printed Tritanium TKA with its cemented counterpart using RSA and clinical outcomes. Authors reported a larger migration of the cementless TKA in the first three months, after which stabilisation was noted in in all cases with the exception of one malaligned TKA that was revised early. No intraoperative navigation or robotic systems were used, therefore weakening reproducibility of implant positioning.

While there have been RCTs comparing cemented to cementless TKA, there is no published study comparing these two groups utilising robotic-arm assistance, which is one of the fastest growing procedures in TKA. Cementless TKA is growing exponentially along with robotic TKA and it would be valuable to ascertain whether there is an advantage of cementless vs cemented TKA.

With the altering demographics of TKA, it is projected that by 2030, 55% of the patients pursuing TKA will be younger than 65 years old. There is a need for high quality evidence on the radiological and clinical benefits of cementless TKA compared to cemented TKA. It is possible to improve on previous studies by incorporating RSA, assessing implant migration and calculating the risk of early implant failure. Our study will also be characterised by high validity; recording a more comprehensive range of clinical and functional outcome measures, blinding patients and using long follow-up times. Furthermore, Mako robotic-arm assistance will be used to improve accuracy of bone resection, guide implant positioning, reduce soft tissue injury, and provide intraoperative assessment of limb alignment; therefore, minimising bias related to surgical variability and inconsistent implant positioning. Findings of this study will enable an improved understanding of the radiological, clinical and functional benefits of cementless fixation compared to cemented fixation in TKA. Findings of the trial could also be used to improve outcomes in total knee arthroplasty; better patient functional outcomes and satisfaction; improved cost-effectiveness by reducing operating time and cement cost; improved long-term implant survival; better outcomes for the exponentially growing number of younger patients pursuing TKA.

The overall aims of this prospective, randomised single-blinded controlled trial are to compare functional, radiological and clinical outcomes in Mako robotic-arm assisted cementless TKA (cementless TKA) versus Mako robotic-arm assisted cemented TKA (cemented TKA). Patients undergoing cemented TKA will form the control group and those undergoing cementless TKA will form the investigation group. A superiority trial design will be used to evaluate whether cementless TKA provides superior outcomes compared to cemented TKA. Radiostereometric analysis (RSA) will be used to assess differences in early and late implant migration between cementless TKA and cemented TKA.

The primary objective of this study is to compare Forgotten Joint score (FJS) at one year following surgery.

This study is a prospective, single-centre, randomised, single-blinded, controlled study. Patients undergoing cemented functionally aligned TKA will form the control group and those undergoing the cementless functionally aligned TKA will form the investigation group.

Being tested
Mako cementless TKA, Mako cemented TKA
Keywords
robotic surgery, cemented implants, uncemented implants, makoplasty, functional outcomes, clinical outcomes, radiological outcomes, inflammatory marker, radiostereometric analysis, RSA
Medical subject headings
Osteoarthritis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mako cementless TKADevice

    Mako robotic-arm assisted total knee arthroplasty using cementless implants

  • Mako cemented TKADevice

    Mako robotic-arm assisted total knee arthroplasty using cemented implants

Study groups in NCT06929871
Study groupRoleWhat they receive
Mako cementless TKAExperimentalMako robotic-arm assisted total knee arthroplasty using cementless implants
Receives: Device: Mako cementless TKA
Mako cemented TKAActive comparatorMako robotic-arm assisted total knee arthroplasty using cemented implants
Receives: Device: Mako cemented TKA

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Forgotten Joint Score [FJS]

    The Forgotten Joint Score (FJS) is a patient-reported outcome measure (PROM) used to assess the degree to which patients have "forgotten" their artificial joint, particularly after joint replacement surgery, like knee replacements.

    The score [100 is best] was developed to measure the success of a joint replacement by evaluating how well a patient has adjusted to the implanted joint in their daily life. It aims to show whether the patient feels like the artificial joint is part of their body and doesn't think about it in normal activities.

    The FJS has a series of questions about:

    • Pain or discomfort in the joint
    • Function and mobility
    • The awareness of the joint during daily activities (e.g., walking, climbing stairs, or sitting)
    • The patient's satisfaction with the joint. A high score means the patient feels that the joint replacement is functioning well and does not interfere with their quality of life, while a lower score may indicate that the patient is not fully satisfied.

    Measured: At one year post-op

Secondary outcomes (24)
  1. Assessement of tibial implant migration by maximum total point motion [MTPM] in millimetres using Radiostereometric analysis (RSA)

    Radiostereometric analysis (RSA) is a highly precise imaging technique used in orthopedic research and clinical practice to track the movement of bones and implants within the body. It uses X-ray images taken from two different angles to create a 3D model of the bones or implants, which allows for highly accurate measurements of their position and motion over time. RSA is particularly useful for evaluating implant movement. It assesses the stability of orthopedic implants - for this outcome the tibial component of the knee prosthesis - to determine if it is moving, which could lead to failure. This study will assess continuous migration between the first and second year post-op, and second and fifth year post-op, measured by maximum total point motion [MTPM]: the maximum displacement observed between two objects (like a bone and an implant, or between two parts of an implant). Measurements are in millimetres [mm]; lower mm is better than higher mm, which could indicate loosening

    Measured: 1, 2 and 5-years post-op

  2. Assess risk of loosening of the knee prosthesis by maximum total point motion [MTPM] in millimetres using Radiostereometric analysis [RSA]

    Radiostereometric analysis [RSA] is a highly precise and advanced imaging technique used in orthopedic research and clinical practice to track the movement of bones and implants within the body. It uses X-ray images taken from two different angles to create a 3D model of the bones or implants, which allows for highly accurate measurements of their position and motion over time.

    RSA is particularly useful for evaluating implant movement. It assesses the stability of orthopedic implants - for this study the knee prosthesis - to determine if it is moving or loosening, which could lead to failure.

    This study will assess continuous migration between the first and second year pos-op, and second and fifth year post-op, measured by maximum total point motion [MTPM]: the maximum displacement observed between two objects (like a bone and an implant, or between two parts of an implant). Measurements are in millimetres [mm]; lower mm is better than higher mm, which could indicate loosening

    Measured: 1, 2 and 5-years post-op

  3. Western Ontario and McMaster Universities Arthritis Index (WOMAC)

    Western Ontario and McMaster Universities Arthritis Index (WOMAC) is a widely used set of questionnaires designed to assess the severity of symptoms in patients, particularly in the knee and hip joints. For this study it is the knee joint It evaluates three main areas:

    Pain: How much pain the person experiences in their joints. Stiffness: How stiff the person feels in their joints. Physical Function: The difficulty the person has with everyday movements and activities.

    The WOMAC score is typically measured using a series of questions related to each of these areas, with responses indicating the level of severity. Each section is scored on a scale, and the total score is used to assess the degree of impact of their affect joint in their everyday life.

    The higher score the worse, the lower score the better outcome: 0 is the best score indicating no problems with pain, stiffness or physical function

    Measured: Preoperatively and postoperatively at 1 year, 2 years and 5 years

  4. The Oxford Knee Score (OKS)

    The Oxford Knee Score (OKS) is a patient completed questionnaire and assesses apatient's knee function and the severity of symptoms related to knee problems, particularly after knee surgery, such as knee replacement.

    The OKS consists of 12 questions related to symptoms, pain, and functional limitations. The questions focus on pain intensity, stiffness, and the ability to perform activities like walking, climbing stairs, and getting in and out of a car. Patients respond to each question on a 5-point scale, where higher scores generally indicate better knee function and less discomfort.

    The total score ranges from 0 to 48, with lower scores indicating more severe knee problems and higher scores indicating less pain and better function.

    Measured: Preoperatively and postoperatively at 1 year, 2 years and 5 years

  5. European Quality of Life questionnaire with 5 dimensions for adults (EQ-5D)

    European Quality of Life questionnaire with 5 dimensions for adults (EQ-5D) is a tool used to measure a person's health-related quality of life. It assesses the impact of health conditions and treatments on a person's well-being.

    There are 2 parts:

    First part includes five dimensions:

    • Mobility
    • Self-care
    • Usual activities
    • Pain/discomfort
    • Anxiety/depression

    For each of these dimensions, the person selects one of three levels:

    • No problems
    • Some problems
    • Severe problems Second part: EQ-5D Visual Analog Scale (VAS): This is a self-rated scale where the person rates their overall health from 0 (worst imaginable health) to 100 (best imaginable health).

    The responses from the descriptive system can also be used to calculate a utility score. '1' is a perfect score, with anything from 0.99 and below a lesser score.

    Measured: 1, 2 and 5-years post-op

  6. Analgesia requirements

    Analgesic medication use: the type and frequency of use of analgesia

    Measured: Up to 90 days; also 1 year and 2 years

  7. Mobility of knee joint

    Range of movement (degrees) of knee joint measured with a goniometer of patient's full knee extension to full knee flexion. Knee extension of >10 degrees and knee flexion of <90 degrees would be a worse outcome; knee extension <10 degrees and knee flexion >90 degrees would be a better outcome

    Measured: Up to 90 days; also 1 year and 2 years

  8. Length of operation

    Operating time (minutes)

    Measured: During operation/surgery

  9. Length of stay

    Time to discharge [minutes]; fewer minutes indicate better outcome

    Measured: Up to 90 days

  10. Preservation of posterior offset by measurement in millimetres of thickness of posterior condyle of the femur

    Measurement of maximum thickness of the posterior condyle projected posteriorly to the tangent of the posterior cortex of the femoral shaft on true lateral radiographs of the knee

    Measured: Pre-operative and day 1 postoperative

  11. Preservation of anterior offset by measurement in millimetres of anterior condyle height and the anterior offset index of the femur

    Measurement in millimetres of the anterior condylar height and the anterior offset index to assess the anterior projection of the femoral condyles.

    Measured: Pre-operative and day 1 post-operative

  12. Complications

    Record any complication as well as need for further surgery. Fewer complications indicate better outcome

    Measured: Through study completion over 5 years

  13. Assess systemic inflammatory reaction incited by cemented or cementless fixation

    Level of serum inflammatory cytokine in picograms per mililitre [pg/ml]: Interleukin-6 [IL-6]

    Measured: 1 week postoperatively

  14. Assess systemic inflammatory reaction incited by cemented or cementless fixation

    Level of serum inflammatory cytokine in picograms per mililitre [pg/ml]: Tumour necrosis factor-alpha [TNFa]

    Measured: 1 week postoperatively

  15. Assess systemic inflammatory reaction incited by cemented or cementless fixation

    Level of serum inflammatory cytokine in picograms per mililitre [pg/ml]: Erythrocyte Sedimentation Rate [ESR]

    Measured: 1 week postoperatively

  16. Assess systemic inflammatory reaction incited by cemented or cementless fixation

    Level of serum inflammatory cytokine in picograms per mililitre [pg/ml]: C-reactive protein [CRP]

    Measured: 1 week postoperatively

  17. Assess systemic inflammatory reaction incited by cemented or cementless fixation

    Level of serum inflammatory cytokine in picograms per mililitre [pg/ml]: Creatinine Kinase [CK]

    Measured: 1 week postoperatively

  18. Operating time costs in pounds sterling

    Comparisons between the two treatment groups relating to: Operating time and the cost in pounds sterling. Fewer pounds sterling indicates better outcome

    Measured: Through study completion over 5 years

  19. Inpatient rehabilitation costs in pounds sterling

    Comparisons between the two treatment groups relating to: Inpatient rehabilitation and the costs in pounds sterling. Fewer pounds sterling indicates better outcome

    Measured: Through study completion over 5 years

  20. Equipment and sterilisation costs in pounds sterling

    Comparisons between the two treatment groups relating to: Equipment and sterilisation and the costs in pounds sterling. Fewer pounds sterling indicates better outcome

    Measured: Through study completion over 5 years

  21. Outpatient rehabilitation costs in pounds sterling

    Comparisons between the two treatment groups relating to: Outpatient rehabilitation and the costs in pounds sterling. Fewer pounds sterling indicates better outcome

    Measured: Through study completion over 5 years

  22. Additional imaging costs - plain x-ray - in pounds sterling

    Comparisons between the two treatment groups relating to: Additional imaging costs of plain x-ray in pounds sterling. Fewer pounds sterling indicates better outcome

    Measured: Through study completion over 5 years

  23. Additional imaging costs - CT scan - in pounds sterling

    Comparisons between the two treatment groups relating to: Additional imaging costs of CT scan in pounds sterling. Fewer pounds sterling indicates better outcome

    Measured: Through study completion over 5 years

  24. Additional imaging costs - ultrasound scan - in pounds sterling

    Comparisons between the two treatment groups relating to: Additional imaging costs of ultrasound scan in pounds sterling. Fewer pounds sterling indicates better outcome

    Measured: Through study completion over 5 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Apr 2025
  2. Study start29 Sep 2025
  3. Primary completion31 Jul 2031 (estimated)
  4. Study completion1 Aug 2031 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
prospective, randomised, single-site, single-blinded trial
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06929871
Sponsor's protocol ID
151407
Status last verified
Feb 2026
First submitted
25 Mar 2025
Last updated
20 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Mako cementless TKA and Mako cemented TKA in people with Total Knee Replacement and Total Knee Replacement Surgery, run by University College, London at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 20 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jenni Tahmassebi, BSc MSc (+442034479403, jenni.tahmassebi1@nhs.net), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Forgotten Joint Score [FJS] (time frame: At one year post-op). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in